Terms: = Leukemia AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Diagnosis
150 results:
1. Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis.
Ren W; Wan H; Own SA; Berglund M; Wang X; Yang M; Li X; Liu D; Ye X; Sonnevi K; Enblad G; Amini RM; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarström Q
Leukemia; 2024 Mar; 38(3):610-620. PubMed ID: 38158444
[TBL] [Abstract] [Full Text] [Related]
2. Renomegaly and acute kidney injury as primary manifestations of non-Hodgkin's lymphoma: a report of three cases.
Bai Y; Zheng Y; Zhang Q; Jiang Q; Diao Z; Guo W; Liu S; Liu W
Diagn Pathol; 2023 Dec; 18(1):133. PubMed ID: 38066507
[TBL] [Abstract] [Full Text] [Related]
3. Spontaneous tumor lysis syndrome in a patient with chronic myeloid leukemia treated successfully with allopurinol.
Gartenberg A; Winkel M; Leonard N
Am J Emerg Med; 2024 Apr; 78():242.e1-242.e3. PubMed ID: 38007380
[TBL] [Abstract] [Full Text] [Related]
4. Poor Outcome of Adult T-Cell leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers.
Saeed H; Sandoval-Sus J; Castillo-Tokumori F; Dong N; Pullukkara JJ; Boisclair S; Brahim A; Walker D; Bridgellal S; Zhang L; Sokol L
Oncol Res Treat; 2023; 46(11):459-465. PubMed ID: 37844559
[TBL] [Abstract] [Full Text] [Related]
5. Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
Zimmermann H; Koenecke C; Dreyling MH; Pott C; Dührsen U; Hahn D; Meidenbauer N; Hauser IA; Rummel MJ; Wolf D; Heuser M; Schmidt C; Schlattmann P; Ritgen M; Siebert R; Oschlies I; Anagnostopoulos I; Trappe RU
Leukemia; 2022 Oct; 36(10):2468-2478. PubMed ID: 35974101
[TBL] [Abstract] [Full Text] [Related]
6. The transformation of isolated gastric myeloid sarcoma into acute myeloid leukemia presenting with a complex karyotype and tls-ERG gene fusion: A case report.
Gao L; Xu Y; Tian Z; Xia J; Yuan Z; Chen D; Ren M
Medicine (Baltimore); 2022 May; 101(21):e29475. PubMed ID: 35623083
[TBL] [Abstract] [Full Text] [Related]
7. A novel HNRNPH1::ERG rearrangement in aggressive acute myeloid leukemia.
Jiang F; Lang X; Chen N; Jin L; Liu L; Wei X; Pan J; Yu F; Blake A; Xiao S
Genes Chromosomes Cancer; 2022 Aug; 61(8):503-508. PubMed ID: 35503261
[TBL] [Abstract] [Full Text] [Related]
8. Colonic infiltration of chronic lymphocytic leukemia with Hodgkin Reed Sternberg-like cells.
Nova-Camacho LM; Val-Carreres Castellote A; Riego Repullo V
Rev Esp Enferm Dig; 2022 Aug; 114(8):510-511. PubMed ID: 35297262
[TBL] [Abstract] [Full Text] [Related]
9. Real-world incidence of venetoclax toxicities in British Columbia.
Lee C; Markarian A; Ladha F; Nakashima L; de Lemos M; Schaff K; Woo S; Gerrie A
J Oncol Pharm Pract; 2022 Jul; 28(5):1163-1169. PubMed ID: 35253497
[TBL] [Abstract] [Full Text] [Related]
10. Fixed-Dose Recombinant Urate Oxidase in the Treatment of Paediatric Tumour Lysis Syndrome: A Regional Cancer Centre Experience.
L A; Reddy JM; Chebbi PG; Kumar N; Ar AK; M P; B S AK
Asian Pac J Cancer Prev; 2021 Dec; 22(12):3897-3901. PubMed ID: 34967569
[TBL] [Abstract] [Full Text] [Related]
11. [Discordant lymphoma of diffuse large B-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified in a human T-cell leukemia virus type-I carrier].
Sumiya C; Kagoo T; Yokoyama A; Yano T; Ueno H
Rinsho Ketsueki; 2021; 62(9):1400-1405. PubMed ID: 34615800
[TBL] [Abstract] [Full Text] [Related]
12. Indeterminate and oncogenic potential: CHIP vs chop mutations in AML with NPM1 alteration.
Cappelli LV; Meggendorfer M; Baer C; Nadarajah N; Hutter S; Jeromin S; Dicker F; Kern W; Haferlach T; Haferlach C; Höllein A
Leukemia; 2022 Feb; 36(2):394-402. PubMed ID: 34376804
[TBL] [Abstract] [Full Text] [Related]
13. Fluid overload and acute kidney injury in children with tumor lysis syndrome.
Flood K; Rozmus J; Skippen P; Matsell DG; Mammen C
Pediatr Blood Cancer; 2021 Dec; 68(12):e29255. PubMed ID: 34302706
[TBL] [Abstract] [Full Text] [Related]
14. Real World Treatment Practices for Mantle Cell Lymphoma in Japan: An Observational Database Research Study (CLIMBER-DBR).
Izutsu K; Suzumiya J; Takizawa J; Fukase K; Nakamura M; Jinushi M; Nagai H
J Clin Exp Hematop; 2021 Sep; 61(3):135-144. PubMed ID: 34092722
[TBL] [Abstract] [Full Text] [Related]
15. Real-world treatment sequencing and healthcare costs among CLL/SLL patients treated with venetoclax.
Rogers KA; Emond B; Manceur AM; Kinkead F; Lafeuille MH; Lefebvre P; Huang Q
Curr Med Res Opin; 2021 Aug; 37(8):1409-1420. PubMed ID: 34003049
[TBL] [Abstract] [Full Text] [Related]
16. Locally advanced malignant solitary fibrous tumour successfully treated with conversion chemotherapy, operation and postoperative radiotherapy: a case report.
Li ZK; Liu J; Chen C; Yang KY; Deng YT; Jiang Y
J Int Med Res; 2021 Mar; 49(3):300060521996940. PubMed ID: 33719644
[TBL] [Abstract] [Full Text] [Related]
17. Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report.
Imoto N; Koyama D; Sugiura I; Kurahashi S
Medicine (Baltimore); 2021 Feb; 100(5):e24457. PubMed ID: 33592897
[TBL] [Abstract] [Full Text] [Related]
18. Reversal of Resistance to Anti-CD20 Antibody Therapies: Targeting Intracellular Resistant Factors.
Navasardyan I; Bonavida B
Crit Rev Oncog; 2020; 25(3):275-290. PubMed ID: 33463946
[TBL] [Abstract] [Full Text] [Related]
19. Autoimmune cytopenia in chronic lymphocytic leukemia: diagnosis and treatment.
Yevstakhevych YL; Vyhovska YI; Yevstakhevych IY; Vyhovska OY; Pelenyo NV; Semerak MM; Novak VL; Loginsky VE
Exp Oncol; 2020 Dec; 42(4):318-323. PubMed ID: 33355861
[TBL] [Abstract] [Full Text] [Related]
20. Cutaneous plaque in adult T cell leukemia/lymphoma: A case report.
Lei CS; Jiang Q; Yu Q; Qiu L
Medicine (Baltimore); 2020 Dec; 99(50):e23491. PubMed ID: 33327284
[TBL] [Abstract] [Full Text] [Related]
[Next]
